44% of Biopharma Companies Increasing Outsourcing Budgets, Study Finds

A survey by BioPlan Associates (Rockville, MD), a market research firm, has found that 44% of biopharmaceutical companies plan to increase their budgets for the outsourcing of manufacturing activities. The findings were part of BioPlan’s 7th Annual Biopharmaceutical Report, which has been published this week. The report features an extensive survey of 327 global biopharma manufacturers and contract manufacturing organizations (CMOs) from 35 countries.   Capacity utilization of biopharma companies' manufacturing assets on average is currently at about...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers